74.20PLN-1.07%Mkt Cap: 174.51M $P/E: —Today
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of comp…
Industry Peers
Medical Devices$198.81BUSDP/E 36.9
$120.66BUSDP/E 34.7
$125.70BUSDP/E 33.9
$111.66BUSDP/E 24.9
$75.37BUSDP/E 21.1
$53.13BUSDP/E 54.9
$48.43BUSDP/E 19.9
$33.94BUSDP/E 17.2
$33.92BUSDP/E 35.5
$25.08BUSDP/E 20.7
$19.21BUSDP/E 24.5
$16.48BUSDP/E 26.9
$12.87BUSDP/E 80.5
$11.86BUSDP/E 22.6
$11.18BUSD
$10.01BUSDP/E 17.1
$10.51BUSDP/E 28.4
$9.73BUSDP/E 19.8
$9.75BUSDP/E 44.3
$8.82BUSDP/E 25.0
Key Statistics
Company
Market Cap174.51M $
Enterprise Value174.82M $
Revenue (TTM)—
Gross Profit-42.04K $
Net Income (TTM)-1.70M $
Revenue/Share—
Last Price74.20 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLMDNCE00016
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-102.17
EV/Revenue—
P/S—
P/B8.09
EPS (TTM)-0.82
EPS (Forward)—
52W Range
8.56076% of range95.10
52W High95.10 PLN
52W Low8.560 PLN
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-7.63%
ROA-7.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.41M $
CapEx (TTM)1.54M $
FCF Margin—
FCF Yield-1.27%
Net Debt-1.57M $
Net Debt/EBITDA0.92
Balance Sheet
Debt/Equity0.00
Current Ratio12.27
Quick Ratio12.21
Book Value/Sh9.359 PLN
Cash/Share0.7150 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.29M
Float7.97M
Insiders8.40%
Institutions27.38%
Technical
SMA 5076.84 (-3.4%)
SMA 20049.80 (+49.0%)
Beta1.09
S&P 52W Chg18.16%
Avg Vol (30d)16.86K
Avg Vol (10d)20.08K
Technical Indicators
RSI (14)47.7
MACD-0.9945
MACD Signal-0.3449
MACD Hist.-0.6496
BB Upper83.78 PLN
BB Middle76.56 PLN
BB Lower69.35 PLN
BB Width18.84%
ATR (14)3.662 PLN
Vol Ratio (20d)0.76x